Nephros (NEPH)
(Delayed Data from NSDQ)
$1.84 USD
+0.04 (1.94%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.77 -0.07 (-3.80%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
NEPH 1.84 +0.04(1.94%)
Will NEPH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NEPH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NEPH
Nephros Inc. (NEPH) Reports Q3 Loss, Misses Revenue Estimates
Lantheus Holdings (LNTH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
NEPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Nephros Inc. (NEPH) Report Negative Earnings Next Week? What You Should Know
Nephros Inc. (NEPH) Reports Q2 Loss, Tops Revenue Estimates
Other News for NEPH
Nephros Shares 2024 Corporate Outlook and Plans
Warning: NEPH is at high risk of performing badly
Nephros’s Strong Fundamentals and Growth Prospects Merit a Buy Rating
Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript
Nephros GAAP EPS of -$0.03, revenue of $3.3M